Using observational data from registries to compare treatments: the fallacy of omnimetrics.

[1]  D. Byar,et al.  Clinical staging for cutaneous T-cell lymphoma. , 1984, Annals of internal medicine.

[2]  O. Miettinen.  The need for randomization in the study of intended effects. , 1983, Statistics in medicine.

[3]  S. Green.  Patient heterogeneity and the need for randomized clinical trials. , 1982, Controlled clinical trials.

[4]  H. Rockette,et al.  Impact of randomized clinical trials on therapy of primary breast cancer: the NSABP overview. , 1982, Controlled Clinical Trials.

[5]  E. Gehan,et al.  Cancer clinical trials. A rational basis for use of historical controls. , 1981, Seminars in oncology.

[6]  S. Ellenberg.  Studies to compare treatment regimens: the randomized clinical trial and alternative strategies. , 1981, JAMA.

[7]  A. Feinstein,et al.  Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction. , 1981, JAMA.

[8]  D. Byar,et al.  Prognostic variables in mycosis fungoides , 1981, Cancer.

[9]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[10]  D. Byar,et al.  Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. , 1979, Cancer treatment reports.

[11]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[12]  J. Ware,et al.  Randomized clinical trials. Perspectives on some recent ideas. , 1976, The New England journal of medicine.

[13]  A. Feinstein,et al.  The application of therapeutic-trial principles to improve the design of epidemiologic research: a case-control study suggesting that anticoagulants reduce mortality in patients with myocardial infarction. , 1981, Journal of chronic diseases.